Aspira Women's Health Inc.
AWHL- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000926617
No open-market purchases or sales by Aspira Women's Health Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Aspira Women's Health Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +3 vs. Q1 2024
- Shares held
- 1.40M
- −496.7K (−26.2%) vs. Q1 2024
- Total value
- $2.08M
- −$4.07M (−66.2%) vs. Q1 2024
- New holders
- 5
- 9 more added
- Sold out
- 2
- 4 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AWHL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $392 |
| Q2 2025 | 2 | $15.7K |
| Q1 2025 | 25 | $81.0K |
| Q4 2024 | 26 | $1.03M |
| Q3 2024 | 25 | $1.91M |
| Q2 2024 | 26 | $2.08M |
| Q1 2024 | 23 | $6.15M |
| Q4 2023 | 24 | $2.92M |
| Q3 2023 | 24 | $3.53M |
| Q2 2023 | 22 | $1.75M |
| Q1 2023 | 45 | $3.25M |
| Q4 2022 | 47 | $3.24M |
| Q3 2022 | 58 | $4.46M |
| Q2 2022 | 72 | $7.02M |
| Q1 2022 | 92 | $22.9M |
| Q4 2021 | 98 | $50.9M |
| Q3 2021 | 92 | $97.0M |
| Q2 2021 | 95 | $174.1M |
| Q1 2021 | 97 | $211.5M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Aspira Women's Health Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Group One Trading, L.P. | 119 | $177 | 0.00% | 00.0% | Unchanged |
| Operose Advisors LLC | 1,000 | $1.49K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,049 | $1.56K | 0.00% | 00.0% | Unchanged |
| Castleview Partners, LLC | 1,316 | $1.96K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2,348 | $3.00K | 0.00% | +2,206+1,553.5% | Added |
| JPMorgan Chase & Co | 2,079 | $3.10K | 0.00% | +2+0.1% | Added |
| Advisor Group Holdings, Inc. | 2,305 | $3.43K | 0.00% | +1,399+154.4% | Added |
| Morgan Stanley | 2,422 | $3.61K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 6,669 | $9.94K | 0.00% | +3,223+93.5% | Added |
| HRT Financial LP | 10,903 | $16.0K | 0.00% | +10,903 | New |
| XTX Topco Ltd | 11,032 | $16.4K | 0.00% | +11,032 | New |
| Citadel Advisors LLC | 11,754 | $17.5K | 0.00% | +11,754 | New |
| Squarepoint Ops LLC | 12,328 | $18.4K | 0.00% | −13,110−51.5% | Reduced |
| Two Sigma Securities, LLC | 13,492 | $20.1K | 0.00% | +13,492 | New |
| M&T Bank Corp | 14,999 | $22.3K | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 15,000 | $22.4K | 0.00% | +15,000 | New |
| State Street Corp | 19,749 | $29.4K | 0.00% | +1,500+8.2% | Added |
| Northeast Financial Consultants Inc | 23,436 | $34.9K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 29,346 | $43.7K | 0.00% | −80.0% | Reduced |
| Northern Trust Corp | 33,015 | $49.2K | 0.00% | −320−1.0% | Reduced |
| Quantum Private Wealth, LLC | 53,418 | $79.6K | 0.03% | +1,000+1.9% | Added |
| Geode Capital Management, LLC | 72,892 | $108.6K | 0.00% | +13,348+22.4% | Added |
| BlackRock Inc. | 73,380 | $109.3K | 0.00% | +10,614+16.9% | Added |
| National Asset Management, Inc. | 236,396 | $352.2K | 0.01% | +111,022+88.6% | Added |
| Vanguard Group Inc | 277,407 | $413.3K | 0.00% | 00.0% | Unchanged |
| Armistice Capital, LLC | 468,000 | $697.3K | 0.02% | −689,000−59.6% | Reduced |
| Fernwood Investment Management, LLC | 0 | $0 | 0.00% | −666−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −51−100.0% | Sold out |